Conoscere EBM
- Definizione
- Acronimi
- Cronologia
- Ambiti
- Know-how e strumenti
- EBM in 4 step
- Limiti e ostacoli

EB Practice
- Formulazione quesito
- Ricerca evidenze
- Valutazione evidenze
- Applicazione evidenze

EBHC Library
- Risorse in italiano

SSN Hot Topics
- Appropriatezza
- Conflitti di interesse
- ECM
- Farmaci
- Governo Clinico
- LEA

InfoSanità

Archivio > News 2006

Page last update: 08/01/2008

• N Engl J Med, 28 dicembre
  • An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
  • Team-Based Prevention of Catheter-Related Infections

18 - 24 dicembre

• BMJ, 23 dicembre
  • Christimas Issue

• Lancet, 23 dicembre
  • Iain Chalmers: maverick master of medical evidence

• N Engl J Med, 21 dicembre
  • Statistics and Medicine: The Limitations of Risk Factors as Prognostic Tools
  • Medical Education: Teaching Surgical Skills — Changes in the Wind
  • Technical-Skills Training in the 21st Century

• Ann Intern Med, 19 dicembre
  • Literacy and Misunderstanding Prescription Drug Labels
  • Improving Patient Care. Effect of a Mailed Brochure on Appointment-Keeping for Screening Colonoscopy: A Randomized Trial
  • Misunderstanding Prescription Labels: The Genie Is Out of the Bottle

11 - 17 dicembre

• Lancet, 16 dicembre
  • Reorganising research in the UK

• BMJ, 16 dicembre
  • The Cooksey review of UK health research funding
  • Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks
  • Drug safety: Anecdotes that provide definitive evidence

• JAMA, 13 dicembre
  • Relationship Between Medicare’s Hospital Compare Performance Measures and Mortality Rates
  • Performance Measures and Clinical Outcomes

• Arch Intern Med, 11/25 dicembre
  • Quality of Care for the Treatment of Acute Medical Conditions in US Hospitals

4 - 10 dicembre

• Lancet, 10 dicembre
  • Global guidelines: is gastroenterology leading the way?
  • Health in an unequal world

• BMJ, 10 dicembre
  • Are New Zealand's new primary health organisations fit for purpose?

• JAMA, 6 dicembre
  • A Pay-for-Population Health Performance System
  • Challenges for Improving Medication Adherence

• Ann Intern Med, 5 dicembre
  • Improving Patient Care.Do Integrated Medical Groups Provide Higher-Quality Medical Care than Individual Practice Associations?
  • Which Type of Medical Group Provides Higher-Quality Care?

• CMAJ, 5 dicembre
  • Institute of Medicine's new drug safety report: implications for Canada
  • EBM and lesser-known ABCD relatives

• Med J Aust, 4-18 dicembre

  • Working to build a healthy Australia: a new era for the NHMRC

  • Research misconduct: can Australia learn from the UK's stuttering system?

  • Australia needs an office of academic integrity

  • Implementing a research governance framework for clinical and public health research

27 novembre - 3 dicembre

• Lancet, 2 dicembre
  • A new discipline is born: comparative health-systems studies

• BMJ, 2 dicembre
  • Diagnosis using search engines
  • Googling for a diagnosis—use of Google as a diagnostic aid: internet based study
  • Does practice based commissioning avoid the problems of fundholding?

• N Engl J Med, 30 novembre
  • Financial Relationships between Institutional Review Board Members and Industry
  • Patients' Views on Financial Conflicts of Interest in Cancer Research Trials
  • Conflict of Interest — or Conflict of Priorities?

20 - 26 novembre

• Lancet, 25 novembre
  • What is publication?
  • Research misconduct: learning the lessons

• BMJ, 25 novembre
  • A model clinical trials agreement
  • How much will Herceptin really cost?

• N Engl J Med, 23 novembre
  • Dangerous Deception — Hiding the Evidence of Adverse Drug Effects
  • Observational Studies of Drug Safety — Aprotinin and the Absence of Transparency
  • Medical Education: Educational Strategies to Promote Clinical Diagnostic Reasoning
  • Building on Experience — The Development of Clinical Reasoning
  • Research Replication

• Ann Intern Med, 21 novembre
  • Alterations in Processes and Priorities Needed for New Drug Development

• CMAJ, 21 novembre
  • A bibliometric analysis by geographic area of published research in several biomedical fields, 1995–2003

• JAMA, 20 novembre
  • Interpreting Surgical Trials With Subjective Outcomes: Avoiding UnSPORTsmanlike Conduct

• Med J Aust, 20 novembre
  • Off-label use of medicines: consensus recommendations for evaluating appropriateness

13 - 19 novembre

• BMJ, 18 novembre
  • Analogies between reading of medical and religious texts

6 - 12 novembre

• BMJ, 11 novembre
  • Investment in health could be good for Europe's economies

• JAMA, 8 novembre
  • Information Technology in the English National Health Service

• Ann Intern Med, 7 novembre
  • Pay-for-Performance and Accountability: Related Themes in Improving Health Care

30 ottobre - 5 novembre

• N Engl J Med, 2 novembre
  • Paying for Performance — Risks and Recommendations
  • Public Report Cards — Cardiac Surgery and Beyond
  • Pay for Performance in Commercial HMOs

23 - 29 ottobre

• BMJ, 28 ottobre
  • The path to safer patients
  • Influenza vaccination: policy versus evidence

• Lancet 28 ottobre
  • Indirect comparisons: the mesh and mess of clinical trials
  • Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses
  • 9 years on: what progress has been made on achieving UK health-care equity?

• N Engl J Med, 26 ottobre
  • Protecting the Health of the Public — Institute of Medicine Recommendations on Drug Safety
  • Blueprint for a Stronger Food and Drug Administration
  • Medical Education: The Developing Physician — Becoming a Professional

• JAMA, 25 ottobre
  • The Rational Clinical Examination. How Do I Perform a Lumbar Puncture and Analyze the Results to Diagnose Bacterial Meningitis?

• CMAJ, 24 ottobre
  • Sources of bias for authors of clinical practice guidelines

16 - 22 ottobre

• Lancet, 21 ottobre
  • Read MEDLINE abstracts with a pinch of salt
  • Rationing is essential in tax-funded health systems

• N Engl J Med 19 ottobre
  • Surviving Sepsis — Practice Guidelines, Marketing Campaigns, and Eli Lilly
  • Stem-Cell Politics
  • FDA Regulation of Stem-Cell–Based Therapies

• JAMA, 18 ottobre
  • National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events

• Ann Intern Med, 17 ottobre
  • Improving Patient Care. Graduate Medical Education and Patient Safety: A Busy—and Occasionally Hazardous—Intersection
  • Quality Grand Rounds: The Case for Patient Safety

9 - 15 ottobre

• BMJ, 14 ottobre
  • Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
  • How to formulate research recommendations

• JAMA, 11 ottobre
  • The Rational Clinical Examination. Do Opiates Affect the Clinical Evaluation of Patients With Acute Abdominal Pain?

• Arch Intern Med, 11 ottobre
  • The FDA and Drug Safety: A Proposal for Sweeping Changes

2- 8 ottobre

• BMJ,7 ottobre
  • Medical education: Trust, competence, and the supervisor's role in postgraduate training

• Lancet, 7 ottobre
  • Institute of Medicine urges reforms at FDA
  • Institutional reviews and innovation in clinical research

• N Engl J Med, 5 ottobre
  • The Price of Sight — Ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration

• JAMA, 4 ottobre
  • COX-2 Inhibitors, Other NSAIDs, and Cardiovascular Risk: The Seduction of Common Sense

• Ann Intern Med, 3 ottobre
  • Missed and Delayed Diagnoses in the Ambulatory Setting: A Study of Closed Malpractice Claims
  • Is Ambulatory Patient Safety Just Like Hospital Safety, Only without the "Stat"?
  • Relationship between Clinical Performance Measures and Outcomes among Patients Receiving Long-Term Hemodialysis

• Med J Aust, 2 ottobre

  • Health and medical research funding: an investment in Australia’s future

• Lancet, 30 settembre
  • The challenge facing the NHS is leadership

• BMJ, 30 settembre
  • Commissioning health education in primary care
  • Parachute approach to evidence based medicine

• N Engl J Med, 28 settembre
  • Delaying Generic Competition — Corporate Payoffs and the Future of Plavix
  • Medical Education: American Medical Education 100 Years after the Flexner Report
  • A Good Teacher
  • A New Series on Medical Education

• Arch Intern Med, 25 settembre
  • Improving Medication Adherence: Challenges for Physicians, Payers, and Policy Makers
  • Numerosi articoli sulla compliance terapeutica

• JAMA, 20 settembre
  • Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease

• Ann Intern Med, 19 settembre
  • Medication Dispensing Errors and Potential Adverse Drug Events before and after Implementing Bar Code Technology in the Pharmacy
  • Narrative Review: The U.S. Pharmacopeia and Model Guidelines for Medicare Part D Formularies

• Med J Aust, 18 settembre
  • Clinical guidelines: what can we do to increase their use?
  • Diabetes guidelines: easier to preach than to practise? A retrospective audit of outpatient management of type 1 and type 2 diabetes mellitus
  • Implementing iron management clinical practice guidelines in patients with chronic kidney disease having dialysis

• BMJ 16 settembre
  • Role of systematic reviews in detecting plagiarism: case of Asim Kurjak
    • Ethical writing should be taught
  • The case of the misleading funnel plot

• JAMA, 13 settembre
  • Peer-Reviewed Publication of Clinical Trials Completed for Pediatric Exclusivity
  • Does This Patient With Headache Have a Migraine or Need Neuroimaging?
  • Moderators of Treatment Outcomes: Clinical, Research, and Policy Importance

• CMAJ, 12 settembre
  • Editorial policy: The right to medical information
  • Online reporting of adverse reactions

• Lancet, 9 settembre
  • Drug bulletins: independent information for global use
  • Bridging the divide: global lessons from evidence-based health policy in Mexico

• BMJ, 9 settembre
  • Challenges for educationalists
  • Evidence based checklists for objective structured clinical examinations

• JAMA, 6 settembre. Theme Issue: Medical Education
  • Accuracy of Physician Self-assessment Compared With Observed Measures of Competence: A Systematic Review
    • Self-assessment in Lifelong Learning and Improving Performance in Practice: Physician Know Thyself
  • Instruments for Evaluating Education in Evidence-Based Practice: A Systematic Review
  • High-Quality Learning for High-Quality Health Care: Getting It Right

• Ann Intern Med, 5 settembre
  • Improving Patient Care. Assessment of the Medicare Quality Improvement Organization Program
    • Enhancing the Potential of Quality Improvement Organizations To Improve Quality of Care
  • Do Oscar Winners Live Longer than Less Successful Peers? A Reanalysis of the Evidence

•  Med J Aust, 4 settembre
  • Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review
  • Clinical paradigms revisited

• N Engl J Med, 31 agosto
  • Primary Care — Will It Survive?
  • Becoming a Physician: Primary Care — The Best Job in Medicine?
  • The Value of Medical Spending in the United States, 1960–2000

• CMAJ, 29 agosto
  • Editorial independence for CMAJ: signposts along the road

• BMJ, 26 agosto
  • Bridging the gaps in evidence based diagnosis
  • Systematic reviews of diagnostic tests in cancer: review of methods and reporting
  • Developing a quality criteria framework for patient decision aids: online international Delphi consensus process
  • Does certification improve medical standards?
  • Evidence based diagnosis: does the language reflect the theory?

• N Engl J Med, 24 agosto
  • Imposing Personal Responsibility for Health
  • Personal Responsibility and Physician Responsibility — West Virginia's Medicaid Plan

• JAMA, 23/30 agosto
  • The Influence of Money on Medical Science

• Med J Aust, 21 agosto

  • The returns from cardiovascular research: the impact of the National Heart Foundation of Australia’s investment

• BMJ, 19 agosto
  • Evidence based publishing

• Ann Intern Med, 15 agosto
  • Improving Patient Care. Does Pay-for-Performance Improve the Quality of Health Care?
  • Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
  • Safeguarding Patient Welfare: Who's In Charge?

• CMAJ, 15 agosto
  • Is there another way to take account of noncompliance in randomized controlled trials?
  • Patent nonsense: Evidence tells of an industry out of social control

• BMJ, 12 agosto
  • Governance of research that uses identifiable personal data
  • Assessment of generalisability in trials of health interventions: suggested framework and systematic review
  • Confidentiality and consent in medical research. 4. Balancing potential risks and benefits of using confidential data

• N Engl J Med, 10 agosto
  • Turning the Page at the CMAJ
  • A Proposal for Radical Changes in the Drug-Approval Process

• JAMA, 9 agosto
  • Tracking Progress in Patient Safety

• Med J Aust, 7 agosto
  • Retractions in the research literature: misconduct or mistakes?

  • Increased expenditure on Australian health and medical research and changes in numbers of publications determined using PubMed

• BMJ, 5 agosto
  • Measuring disparities in health care
  • Health professionals' and service users' interpretation of screening test results: experimental study
  • Confidentiality and consent in medical research. 3. Overcoming barriers to recruitment in health research

• N Engl J Med, 3 agosto
  • Access before Approval — A Right to Take Experimental Drugs?

• BMJ, 29 luglio
  • Believability of relative risks and odds ratios in abstracts: cross sectional study
  • An independent NHS?
  • Confidentiality and consent in medical research. 2. Consent for the use of personal medical data in research

• N Engl J Med, 27 luglio
  • Business and Medicine: The Price of Growth in the Medical-Device Industry
  • Pay-for-Performance Programs in Family Practices in the United Kingdom
  • Paying for Performance in the United States and Abroad
  • The Troubled Transformation of Britain's National Health Service

• BMJ, 21 luglio
  • Regulation and revalidation of doctors
  • Confidentiality and consent in medical research. 1. Confidentiality of personal health information used for research

• Lancet, 21 luglio
  • Funding for practice-oriented clinical research

• N Engl J Med, 20 luglio
  • The "Gender Gap" in Authorship of Academic Medical Literature — A 35-Year Perspective
  • Women in Academic Medicine — Progress and Challenges

• CMAJ, 18 luglio
  • Canadian clinicians and patients need clean, clear knowledge

• Ann Intern Med, 18 luglio
  • Improving Patient Care. The Association between Quality of Care and the Intensity of Diabetes Disease Management Programs

• Med J Aust, 17 luglio
  • Extent and utilisation of computerisation in Australian general practice
  • General practitioners’ use of computers for prescribing and electronic health records: results from a national survey

  • Information mastery and the 21st century doctor: change management for general practitioners

  • Information mastery and 21st century general practice

  • Supporting research in primary care: are practice-based research networks the missing link?

  • What supports effective research links between Divisions of General Practice and universities?

  • Primary health care research — essential but disadvantaged

• Lancet, 15 luglio
  • Effects of the medical liability system in Australia, the UK, and the USA

• N Engl J Med, 13 luglio
  • Statistics and Medicine: Time-to-Event Analyses for Long-Term Treatments — The APPROVe Trial
  • System Failure versus Personal Accountability — The Case for Clean Hands

• JAMA, 12 luglio
  • Update on JAMA's Conflict of Interest Policy

• Lancet, 8 luglio
  • Is the FDA going easy on violators?
  • Health research in the UK: the price of success

• BMJ, 8 luglio
  • Drug regulation: Did regulators fail over selective serotonin reuptake inhibitors?

• JAMA, 5 luglio
  • Hospital Quality for Acute Myocardial Infarction: Correlation Among Process Measures and Relationship With Short-term Mortality
  • Measuring Hospital Quality: What Physicians Do? How Patients Fare? Or Both?

• Ann Intern Med, 4 luglio
  • Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials

• CMAJ, 4 luglio
  • Conflicts cause FDA to review advisory committees

• BMJ, 1 luglio
  • Can patients assess the quality of health care?
  • Soft paternalism and the ethics of shared electronic patient records
  • The NHS programme for information technology
  • A meta-analysis of the association between adherence to drug therapy and mortality
  • Commentary: The healthy adherer and the placebo effect

• Lancet, 1 luglio
  • Funding of patients’ groups
  • Evidence for health-system reform: a call to action
  • Evolution of hypertensive disease: a revolution in guidelines

• N Engl J Med, 29 giugno
  • The New Era of Medical Imaging — Progress and Pitfalls

• Lancet, 24 giugno
  • Are systematic reviews more cost-effective than randomised trials?
  • Systematic reviews: when is an update an update?

• BMJ, 24 giugno
  • Is restricted randomisation necessary?

• JAMA, 21 giugno
  • How Conducting a Clinical Trial Affects Physicians' Guideline Adherence and Drug Preferences
  • Expected and Unanticipated Consequences of the Quality and Information Technology Revolutions
  • Clinical Trial Investigators and Their Prescribing Patterns: Another Dimension to the Relationship Between Physician Investigators and the Pharmaceutical Industry

• CMAJ, 20 giugno
  • Editorial policy: industry funding and editorial independence
  • Re-examining our approach to the approval and use of new drugs
  • Evidence and advocacy: Are all things considered?

• Ann Intern Med, 20 giugno
  • Quality of Care for Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
  • Redesigning Residency Education in Internal Medicine: A Position Paper from the Association of Program Directors in Internal Medicine
  • Redesigning Training for Internal Medicine
  • Internal Medicine Training: Putt or Get Off the Green

• Med J Aust, 19 giugno

  • Killing the messenger: should scientific journals be responsible for policing scientific fraud?

  • The Greater Metropolitan Clinical Taskforce: an Australian model for clinician governance

  • Should clinical software be regulated?

  • Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals

• Bandolier, 143

• Lancet, 17 giugno
  • Clinical trials in children, for children
  • Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care

• BMJ, 17 giugno
  • Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
  • Quality improvement report: Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study
  • Commercial influence and the content of medical journals
  • The price of independence

• JAMA; 14 giugno
  • NIH Support for Basic and Clinical Research: Biomedical Researcher Angst in 2006

• Arch Intern Med, 12 giugno
  • Sex Differences in the Application of Evidence-Based Therapies for the Treatment of Acute Myocardial Infarction: The American College of Cardiology's Guidelines Applied in Practice Projects in Michigan

• Lancet, 10 giugno
  • Scientific misconduct: a new approach to prevention

• BMJ, 10 giugno
  • The great medicines scandal
  • Quality improvement: Saving 100 000 lives in US hospitals

• JAMA; 7 giugno
  • Effect of a Clinical Pathway to Reduce Hospitalizations in Nursing Home Residents With Pneumonia: A Randomized Controlled Trial

   

• Ann Intern Med, 6 giugno
  • When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials?

• Med J Aust, 6 giugno
  • Evidence into practice: the mental health hurdle is high

  • Sackings at the Canadian Medical Association Journal and editorial independence

  • Public reporting of hospital outcomes based on administrative data: risks and opportunities

  • Media reporting on research presented at scientific meetings: more caution needed

• BMJ, 3 giugno
  • More money for medical research

• Lancet, 3 giugno
  • A second chance for the UK to reduce drug-misuse deaths
  • Making the NHS cost effective

• Bandolier, 142

• BMJ, 27 maggio
  • Statistics in practice: The simplest statistical test: how to check for a difference between treatments
  • Review of NICE's recommendations, 1999-2005
  • Resource allocation: NICE work
  • How NICE may be outflanked

• JAMA, 24-31 maggio
  • Protecting Special Interests in the Name of "Good Science"

• CMAJ, 23 maggio
  • Reflecting on governance for CMAJ
  • Are there better ways to determine wait times?
  • Getting physicians to accept new information technology: insights from case studies
  • Physicians will happily adopt information technology

• Lancet, 20 maggio
  • Independence at the US Food and Drug Administration
  • Clinical trial registration: transparency is the watchword
  • Trial registers: protecting patients, advancing trust
  • Trial summaries on results databases and journal publication
  • US Food and Drug Administration pushed to change
  • Reversing the decline of academic medicine in Europe

• JAMA, 17 maggio
  • Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000-2005

• Ann Intern Med, 16 maggio
  • Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care
  • Health Information Technology: Shall We Wait for the Evidence?

• Bandolier, 141

• BMJ, 13 maggio
  • An international standard for disclosure of clinical trial information
  • Sample sizes of studies on diagnostic accuracy: literature survey
  • Improving the quality and clinical relevance of diagnostic studies
  • Informed choice for screening: implications for evaluation

• N Engl J Med, 11 maggio
  • Claims, Errors, and Compensation Payments in Medical Malpractice Litigation
  • The Patient's Right to Safety — Improving the Quality of Care through Litigation against Hospitals

• BMJ, 6 maggio
  • Origin and funding of the most frequently cited papers in medicine: database analysis
  • Is society losing control of the medical research agenda? 
  • Statistics Notes: The cost of dichotomising continuous variables
  • Research protocols: Waiving confidentiality for the greater good
  • Comparative accuracy: assessing new tests against existing diagnostic pathways 

• N Engl J Med, 4 maggio
  • Injury to Research Volunteers — The Clinical-Research Nightmare
  • Compensation for Injured Research Subjects
  • Shattuck Lecture. The Family Business — To Educate

• JAMA, 3 maggio
  • How the US Drug Safety System Should Be Changed

• Med J Aust, 1 maggio

  • Preventing and processing research misconduct: a new Australian code for responsible research

  • The Research Quality Framework and its implications for health and medical research: time to take stock?

• JAMA, 26 aprile
  • Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes
  • Financial Conflict of Interest Disclosure and Voting Patterns at Food and Drug Administration Drug Advisory Committee Meetings
  • Using Clinical Guidelines Designed for Older Adults With Diabetes Mellitus and Complex Health Status

• Lancet, 22 aprile
  • Putting a value on medical research
  • Effect of a US National Institutes of Health programme of clinical trials on public health and costs

• BMJ, 22 aprile
  • Are virtual communities good for our health?
  • Accuracy and self correction of information received from an internet breast cancer list: content analysis
  • Effect of different forms of information produced for cancer patients on their use of the information, social support, and anxiety: randomised trial
  • Importance of relative measures in policy on health inequalities
  • Reporting attrition in randomised controlled trials

• N Engl J Med , 21 aprile
  • The NIH Budget and the Future of Biomedical Research
  • The Challenge of Subgroup Analyses — Reporting without Distorting

• JAMA, 19 aprile
  • Second-Order Peer Review of the Medical Literature for Clinical Practitioners
  • Will Physician-Level Measures of Clinical Performance Be Used in Medical Malpractice Litigation?

• Ann Intern Med, 18 aprile
  • Research Misconduct, Retraction, and Cleansing the Medical Literature: Lessons from the Poehlman Case

• Med J Aust, 17 aprile

  • Accessing health outcome data on high-cost medicines in Australia

  • Teaching on the run tips 13: being a good supervisor — preventing problems

• Lancet, 15 aprile
  • Urgent changes needed for authorisation of phase I trials

• BMJ, 15 aprile
  • Medical academia is failing patients and clinicians
  • Health service reform: Seven years of feast, seven years of famine: boom to bust in the NHS?

• Bandolier, 138

• N Engl J Med, 13 aprile
  • Access to the Scientific Literature — A Difficult Balance

• JAMA, 12 aprile
  • Effect of Blinded Peer Review on Abstract Acceptance
  • Recent Trials in Hypertension: Compelling Science or Commercial Speech?

• CMAJ, 11 aprile
  • Prioritizing and stopping prescription medicines
  • An innovative approach to involve patients in measuring treatment effects in drug trials
  • Do manufacturers of brand-name drugs engage in price competition? An analysis of introductory prices

• BMJ, 8 aprile
  • Referral management centres: promising innovations or Trojan horses?
    • Commentary: Patients are not commodities
    • Commentary: Not another innovation
  • Regulation of biomedical research in Africa

• Ann Intern Med, 4 aprile
  • Computerization Can Create Safety Hazards: A Bar-Coding Near Miss

• Med J Aust, 3 aprile
  • Medical education in Australia: changes are needed
  • Lack of integration of medical education in Australia: the need for change

• Lancet, 1 aprile
  • Trialists should tell participants results, but how?

• CMAJ, 28 marzo
  • Editorial autonomy of CMAJ
  • Editorial Governance Plan for CMAJ

• Arch Intern Med, 27 marzo
  • Time, Now, to Recover the Fun in the Physical Examination Rather Than Abandon It

• BMJ, 25 marzo
  • Bias in published cost effectiveness studies: systematic review

• Ann Intern Med, 21 marzo
  • Evaluation of the Quality of Prognosis Studies in Systematic Reviews

• Med J Aust, 20 marzo
  • Evaluation of NHMRC funded research completed in 1992, 1997 and 2003: gains in knowledge, health and wealth

• BMJ, 18 marzo
  • What sort of evidence do we need in primary care
  • Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study
  • Information technology. 2. Keeping the NHS electronic spine on track

• Lancet, 18 marzo
  • Systematic reviews: when is an update an update?

• N Engl J Med, 16 marzo
  • Who Is at Greatest Risk for Receiving Poor-Quality Health Care?

• JAMA, 15 marzo
  • Transition From Meeting Abstract to Full-length Journal Article for Randomized Controlled Trials

• CMAJ, 14 marzo
  • Is medicine still a profession?
  • Can we develop wait lists for public health issues?

• Arch Intern Med, 13 marzo
  • The Proof for Prevention: Beyond Observations
  • Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization

• BMJ, 11 marzo
  • Information technology.  1.Will Connecting for Health deliver its promises?

• Lancet 11 marzo
  • Assessing outcomes in individually-tailored interventions

• JAMA, 8 marzo
  • Quality of Reporting of Noninferiority and Equivalence Randomized Trials
  • Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement
  • Lessons From and Cautions About Noninferiority and Equivalence Randomized Trials
  • All-or-None Measurement Raises the Bar on Performance

• Ann Intern Med, 7 marzo
  • Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement

• Med J Aust, 6 marzo
  • Teaching on the run tips 12: planning for learning during clinical attachments

• BMJ, 4 marzo
  • Where expert witnesses fear to tread
  • Harmful impact of EU clinical trials directive
  • Adjusting for treatment refusal in rationing decisions

• Lancet, 4 marzo
  • Secret science: tobacco industry research on smoking behaviour and cigarette toxicity

• CMAJ, 28 febbraio
  • Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies
  • What is the best evidence for determining harms of medical treatment?
  • "You can't always get what you want" — Or can you?

• Arch Intern Med, 27 febbraio
  • Decision Making at the Fringe of Evidence: Take What You Can Get

• Bandolier, 137

• BMJ, 25 febbraio
  • Behavioural medicine: changing our behaviour
  • Using economics to set pragmatic and ethical priorities

• N Engl J Med, 23 febbraio
  • Strategies for Improving Surgical Quality — Should Payers Reward Excellence or Effort?

• Ann Intern Med, 21 febbraio
  • Better Ways To Question Patients about Adverse Medical Events: A Randomized, Controlled Trial
  • Adverse Events: The More You Search, the More You Find
  • Volume, Quality of Care, and Outcome in Pneumonia

• Il Sole 24 Ore Sanità, 21 febbraio
  • Report 1a Conferenza Nazionale GIMBE^®

• Lancet, 28 febbraio
  • Comorbidity and guidelines: conflicting interests

• BMJ, 28 febbraio
  • Determinants of primary medical care quality measured under the new UK contract: cross sectional study
  • Sham device v inert pill: randomised controlled trial of two placebo treatments
  • Importance of free access to research articles on decision to submit to the BMJ: survey of authors
  • Process evaluation in randomised controlled trials of complex interventions
  • Lessons for clinical trials from natalizumab in multiple sclerosis
  • Have targets improved performance in the English NHS?

• Evidence-based Medicine, febbraio 2006
  • 3rd International Conference of Evidence-Based Health Care Teachers & Developers

• CMAJ, 14 febbraio
  • Are journals doing enough to prevent fraudulent publication?
  • Evidence of bias and variation in diagnostic accuracy studies
  • Sources of bias in diagnostic accuracy studies and the diagnostic process
  • Nonpatentable drugs and the cost of our ignorance

• Report 1^a Conferenza Nazionale GIMBE^®</